Your browser doesn't support javascript.
loading
Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence.
Wang, Qin; Würtz, Peter; Auro, Kirsi; Mäkinen, Ville-Petteri; Kangas, Antti J; Soininen, Pasi; Tiainen, Mika; Tynkkynen, Tuulia; Jokelainen, Jari; Santalahti, Kristiina; Salmi, Marko; Blankenberg, Stefan; Zeller, Tanja; Viikari, Jorma; Kähönen, Mika; Lehtimäki, Terho; Salomaa, Veikko; Perola, Markus; Jalkanen, Sirpa; Järvelin, Marjo-Riitta; Raitakari, Olli T; Kettunen, Johannes; Lawlor, Debbie A; Ala-Korpela, Mika.
  • Wang Q; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Würtz P; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Auro K; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Mäkinen VP; National Institute for Health and Welfare, Helsinki, Finland.
  • Kangas AJ; Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.
  • Soininen P; Department of Obstetrics and Gynecology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Tiainen M; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Tynkkynen T; Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Jokelainen J; School of Biological Sciences, University of Adelaide, Adelaide, Australia.
  • Santalahti K; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Salmi M; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Blankenberg S; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Zeller T; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Viikari J; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Kähönen M; Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Lehtimäki T; NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Salomaa V; Center for Life Course Health Research and Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Perola M; Unit of Primary Care, Oulu University Hospital, Oulu, Finland.
  • Jalkanen S; Department of Medical Microbiology and Immunology, and MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Järvelin MR; Department of Medical Microbiology and Immunology, and MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Raitakari OT; Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
  • Kettunen J; German Center for Cardiovascular Research (DZHK e.V.), partner site Hamburg, Lübeck, Kiel, Germany.
  • Lawlor DA; Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
  • Ala-Korpela M; German Center for Cardiovascular Research (DZHK e.V.), partner site Hamburg, Lübeck, Kiel, Germany.
BMC Med ; 14(1): 205, 2016 Dec 13.
Article en En | MEDLINE | ID: mdl-27955712
ABSTRACT

BACKGROUND:

Pregnancy triggers well-known alterations in maternal glucose and lipid balance but its overall effects on systemic metabolism remain incompletely understood.

METHODS:

Detailed molecular profiles (87 metabolic measures and 37 cytokines) were measured for up to 4260 women (24-49 years, 322 pregnant) from three population-based cohorts in Finland. Circulating molecular concentrations in pregnant women were compared to those in non-pregnant women. Metabolic profiles were also reassessed for 583 women 6 years later to uncover the longitudinal metabolic changes in response to change in the pregnancy status.

RESULTS:

Compared to non-pregnant women, all lipoprotein subclasses and lipids were markedly increased in pregnant women. The most pronounced differences were observed for the intermediate-density, low-density and high-density lipoprotein triglyceride concentrations. Large differences were also seen for many fatty acids and amino acids. Pregnant women also had higher concentrations of low-grade inflammatory marker glycoprotein acetyls, higher concentrations of interleukin-18 and lower concentrations of interleukin-12p70. The changes in metabolic concentrations for women who were not pregnant at baseline but pregnant 6 years later (or vice versa) matched (or were mirror-images of) the cross-sectional association pattern. Cross-sectional results were consistent across the three cohorts and similar longitudinal changes were seen for 653 women in 4-year and 497 women in 10-year follow-up. For multiple metabolic measures, the changes increased in magnitude across the three trimesters.

CONCLUSIONS:

Pregnancy initiates substantial metabolic and inflammatory changes in the mothers. Comprehensive characterisation of normal pregnancy is important for gaining understanding of the key nutrients for fetal growth and development. These findings also provide a valuable molecular reference in relation to studies of adverse pregnancy outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Embarazo / Metabolómica Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Embarazo / Metabolómica Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged País como asunto: Europa Idioma: En Año: 2016 Tipo del documento: Article